pcDNA3-Casp9 C287A Citations (4)
Originally described in: Caspase-9 can be activated without proteolytic processing.Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS J Biol Chem. 1999 Mar 26. 274(13):8359-62. PubMed Journal
Articles Citing pcDNA3-Casp9 C287A
Articles |
---|
Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. Boston SR, Deshmukh R, Strome S, Priyakumar UD, MacKerell AD Jr, Shapiro P. BMC Cancer. 2011 Jan 10;11:7. doi: 10.1186/1471-2407-11-7. PubMed |
Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid. Pesakhov S, Nachliely M, Barvish Z, Aqaqe N, Schwartzman B, Voronov E, Sharoni Y, Studzinski GP, Fishman D, Danilenko M. Oncotarget. 2016 May 31;7(22):31847-61. doi: 10.18632/oncotarget.7240. PubMed |
Optimization of Experimental Variables Influencing Apoptosome Biosensor in HEK293T Cells. Oladzad A, Nikkhah M, Hosseinkhani S. Sensors (Basel). 2020 Mar 23;20(6). pii: s20061782. doi: 10.3390/s20061782. PubMed |
GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells. Booth L, West C, Von Hoff D, Kirkwood JM, Dent P. Front Oncol. 2021 Apr 8;11:656453. doi: 10.3389/fonc.2021.656453. eCollection 2021. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.